⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28868986 | 0.76 | — | — | |
| SCHEMBL4184592 | 0.76 | — | — | |
| SCHEMBL9821780 | 0.76 | — | — | |
| SCHEMBL9324320 | 0.76 | — | — | |
| SCHEMBL173628 | 0.76 | F2 (0.46) | — | |
| SCHEMBL16013353 | 0.75 | PKM (0.51) | — | |
| SCHEMBL17629245 | 0.74 | F2 (0.61) | — | |
| SCHEMBL13011203 | 0.72 | POLB (0.49) | — | |
| SCHEMBL18464502 | 0.72 | F2 (0.44) | — | |
| SCHEMBL28621632 | 0.72 | F2 (0.44) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-106170489-B | New Pyrazolopyrimidine derivative and its purposes as MALT1 inhibitor | 诺华股份有限公司 | 2019-05-03 | — | — | CN | disclosed |
| CN-105669558-B | Benzyl -1H- pyrazoles, benzyl -1H- azole derivatives and its preparation method and application | 四川大学 | 2019-01-22 | — | — | CN | disclosed |
| CN-108929336-A | Thiazolopyrimidinone class as the active regulator of nmda receptor | 豪夫迈·罗氏有限公司 | 2018-12-04 | — | — | CN | disclosed |
| CN-108473499-A | Novel Pyrazolopyrimidine derivative | 诺华股份有限公司 | 2018-08-31 | — | — | CN | disclosed |
| CN-105612162-B | Thiazolopyrimidinones as modulators of NMDA receptor activity | 豪夫迈·罗氏有限公司 | 2018-08-21 | — | — | CN | disclosed |
| CN-105612162-A | Thiazolopyrimidinones as modulators of NMDA receptor activity | HOFFMANN LA ROCHE | 2016-05-25 | — | — | CN | disclosed |